- Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
- Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
- Olink reports first quarter 2024 financial results
- Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
- Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
- Olink publishes 2023 annual report
- Olink reports fourth quarter and full year 2023 financial results
- Notice to attend the Annual General Meeting of Olink Holding AB (publ)
- Olink announces change of date for Annual General Meeting
- Olink reports third quarter 2023 financial results
More ▼
Key statistics
As of last trade Olink Holding AB (publ) (6XA:DUS) traded at 22.40, -6.67% below its 52-week high of 24.00, set on Dec 11, 2023.
52-week range
Open | 22.40 |
---|---|
High | 22.40 |
Low | 22.40 |
Bid | 22.40 |
Offer | 23.20 |
Previous close | 22.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 124.34m |
Free float | 41.50m |
P/E (TTM) | -- |
Market cap | 3.03bn USD |
EPS (TTM) | -0.2704 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 08:31 BST.
More ▼